» Articles » PMID: 23950588

Modulatory Effects of Sesamol in Dinitrochlorobenzene-induced Inflammatory Bowel Disorder in Albino Rats

Overview
Journal Pharmacol Rep
Specialty Pharmacology
Date 2013 Aug 17
PMID 23950588
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inflammatory bowel disease (IBD) is a chronic inflammatory condition of gastrointestinal tract of immune, genetic and environmental origin. In the present study, we examined the effect of sesamol (SES), the main anti-oxidative constituent of Sesamum indicum (sesame seed) Linn. in the dinitrochlorobenzene (DNCB)-induced model for IBD in rats.

Methods: The groups were divided into normal control, DNCB control, SES and sulfasalazine (SS). On day 24, the rats were killed, colon removed and the macroscopic, biochemical and histopathological evaluations were performed.

Results: The levels of MPO, TBARS and nitrite increased significantly (p < 0.05) in the DNCB group, whereas reduced significantly in the SES, SS treated groups. Serum nitrite levels were found to be insignificant between the different groups. IL-6 and TNF-α levels were significantly high in the DNCB group.

Conclusions: We conclude the mucosal protective effect of SES on colon due to its potent antioxidant actions. Further investigation is required in a chronic model of different rodent strain for its role involved in the cytokine pathway.

Citing Articles

Sesamol as a potent anticancer compound: from chemistry to cellular interactions.

Kumar A, Bajaj P, Singh B, Paul K, Sharma P, Mehra S Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(7):4961-4979.

PMID: 38180556 DOI: 10.1007/s00210-023-02919-2.


Sesamol combats diabetogenic effects of atorvastatin through GLUT-4 expression and improved pancreatic viability.

Keni R, Nayak P, Kumar N, Kishore A, Alnasser S, Begum F 3 Biotech. 2023; 13(11):377.

PMID: 37885753 PMC: 10597939. DOI: 10.1007/s13205-023-03784-9.


Hypolipidemic and Anti-Atherogenic Effects of Sesamol and Possible Mechanisms of Action: A Comprehensive Review.

Majdalawieh A, Eltayeb A, Abu-Yousef I, Yousef S Molecules. 2023; 28(8).

PMID: 37110801 PMC: 10146572. DOI: 10.3390/molecules28083567.


Formulation Strategies for Enhancing Pharmaceutical and Nutraceutical Potential of Sesamol: A Natural Phenolic Bioactive.

Nair A, Dalal P, Kadian V, Kumar S, Garg M, Rao R Plants (Basel). 2023; 12(5).

PMID: 36904028 PMC: 10005287. DOI: 10.3390/plants12051168.


Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug.

Martinez Monteros M, Galdeano C, Balcells M, Weill R, De Paula J, Perdigon G Sci Rep. 2021; 11(1):571.

PMID: 33436961 PMC: 7803994. DOI: 10.1038/s41598-020-80482-z.